U.S. Environmental Protection Agency (EPA) Administrator Andrew Wheeler signed a directive to prioritize efforts to reduce animal testing. Administrator Wheeler also announced $4.25 million in funding to five universities to research the development and use of alternative test methods and strategies that reduce, refine, and/or replace vertebrate animal testing.
“Memo directs the agency to aggressively reduce animal testing, including reducing mammal study requests and funding 30% by 2025 and completely eliminating them by 2035,” said EPA Administrator Andrew Wheeler. “We are also awarding $4.25 million to advance the research and development of alternative test methods for evaluating the safety of chemicals that will minimize, and hopefully eliminate, the need for animal testing.”
In the memo, Administrator Wheeler calls for the agency to aggressively pursue a reduction in animal testing. The memo states, EPA will reduce its requests for, and funding of, mammal studies by 30% by 2025 and eliminate all mammal study requests and funding by 2035. Any mammal studies requested or funded by EPA after 2035 will require administrator approval on a case by case basis. It directs leadership and staff in the Office of Chemical Safety and Pollution Prevention and the Office of Research and Development to prioritize ongoing efforts and to direct existing resources toward additional activities that will demonstrate measurable impacts in the reduction of animal testing while ensuring protection of human health and the environment.
In accordance with the memo, EPA will hold an annual conference on new approach methods beginning in 2019.
To read the full memo, visit https://www.epa.gov/environmental-topics/administrator-memo-prioritizing-efforts-reduce-animal-testing-september-20-2019.
In addition to the memo, five universities were awarded grants through the agency’s Science to Achieve Results Program. The research focuses on advancing the development and use of alternative test methods and strategies to reduce, refine, and/or replace vertebrate animal testing. The grantees are advancing the science of non-vertebrate alternative test methods and strategies in chemical hazard assessment.
· Johns Hopkins University to develop a human-derived brain model to assess the mechanism by which environmental chemicals might cause developmental neurotoxicity.
· Vanderbilt University to test their organ-on-a-chip to study the blood brain barrier and potential brain injury after organophosphate exposure.
· Vanderbilt University Medical Center to use their Endo Chip technology to research how preexisting diseases affect cellar responses to environmental toxicants with a focus on reproductive disorders in women.
· Oregon State University to develop in vitro test methods for fish species to screen chemicals in complex environmental mixtures.
· University of California Riverside to use human cells to develop a cost-effective endpoint to characterize potential skeletal embryotoxicants.
Related Reports and Monitors
Inkjet Printheads: Dispensing Technologies & Market Landscape 2019
Market & Technology
Status of the Microfluidics Industry 2019
Market & Technology